Experienced in Riboflavin Transporter Deficiency Neuronopathy

Edvard Ehler

Pardubice, PA, CZ 
Experienced in Riboflavin Transporter Deficiency Neuronopathy
Pardubice, PA, CZ 
OverviewLocationsClinical Research

Overview

Edvard Ehler practices in Pardubice, Czech Republic. Mr. Ehler is rated as an Experienced expert by MediFind in the treatment of Riboflavin Transporter Deficiency Neuronopathy. His top areas of expertise are Chronic Polyradiculoneuritis, Chronic Inflammatory Demyelinating Polyneuropathy, Diabetic Neuropathy, Torticollis, and Gastrostomy.

His clinical research consists of co-authoring 52 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Riboflavin Transporter Deficiency Neuronopathy.

Gender
Male

Locations

Pardubice, PA, Czech Republic
Other Locations
Prague, PR 12800, Czech Republic

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 2 Placebo-Controlled, Double-Blind, Enriched Enrollment Randomized Withdrawal Study to Evaluate the Efficacy and Safety of BIIB074 (Vixotrigine) in Treating Pain Experienced by Subjects With Confirmed Small Fiber Neuropathy That is Idiopathic or Associated With Diabetes Mellitus
A Phase 2 Placebo-Controlled, Double-Blind, Enriched Enrollment Randomized Withdrawal Study to Evaluate the Efficacy and Safety of BIIB074 (Vixotrigine) in Treating Pain Experienced by Subjects With Confirmed Small Fiber Neuropathy That is Idiopathic or Associated With Diabetes Mellitus
Enrollment Status: Terminated
Publish Date: May 05, 2021
Intervention Type: Drug
Study Drug: BIIB074
Study Phase: Phase 2
Efficacy and Safety of Low Doses of Trazodone in Patients Affected by Painful Diabetic Neuropathy: Randomized, Controlled, Pilot Study.
Efficacy and Safety of Low Doses of Trazodone in Patients Affected by Painful Diabetic Neuropathy: Randomized, Controlled, Pilot Study.
Enrollment Status: Completed
Publish Date: September 28, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

52 Total Publications

Loss of ADAR1 protein induces changes in small RNA landscape in hepatocytes.
Loss of ADAR1 protein induces changes in small RNA landscape in hepatocytes.
Journal: RNA (New York, N.Y.)
Published: May 14, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ehler's expertise for a condition
ConditionClose
      View All 21 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile